OxcarbazepineLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1905卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14799-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：409 / 409

相关论文

共 50 条

[1] AntibacterialsLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1920 (1) : 43 - 43
[2] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 259 - 259
[3] EculizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2021, 1862 (1) : 196 - 196
[4] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2041 (1) : 398 - 398
[5] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1967 (1) : 143 - 143
[6] FavipiravirLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 254 - 254
[7] AmiodaroneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1969 (1) : 29 - 29
[8] RituximabLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1905 (1) : 444 - 444
[9] ChlorhexidineLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2055 (1) : 96 - 96
[10] FluoxetineLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1939 (1) : 219 - 219

← 1 2 3 4 5 →